Glucose metabolism alterations and Aβ deposition in AD and FTD are related to the distribution of neurotransmitter systems
European Journal of Nuclear Medicine and Molecular Imaging · 2026
DOI: 10.1007/s00259-025-07485-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Sheng Bi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology & Nuclear Medicine, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Xicheng District, Beijing, 100053, Chin…. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurotransmitter Agents, Glucose, Amyloid beta-Peptides. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
OBJECTIVE: This study aimed to elucidate the spatial correlations among alterations in glucose metabolism, amyloid-beta (Aβ) deposition, and neurotransmitter systems across Alzheimer's disease (AD), mild cognitive impairment (MCI) and frontotemporal dementia (FTD), while assessing their associations with clinical cognitive decline. METHODS: In this retrospective cohort study, 507 participants (261 AD, 111 MCI, 62 FTD and 73 normal controls) underwent multimodal neuroimaging, including 18F-FDG PET, 18F-AV45 Aβ PET, and structural MRI. Spatial co-localization of imaging alterations with neurotransmitter receptor/transporter distributions was assessed using the JuSpace toolbox. Spearman correlations evaluated associations between imaging-neurotransmitter co-localization and cognitive scores. False discovery rate (FDR) correction was used to control for P < 0.05 for all analyses. RESULTS: AD showed glucose hypometabolism in temporoparietal and frontal regions, while FTD was observed in the frontotemporal areas. Spatial co-localization analyses revealed subtype-specific neurotransmitter vulnerabilities: AD glucose hypometabolism correlated with serotonergic, γ-aminobutyric acidergic (GABAergic), dopaminergic, and glutamatergic systems, while FTD correlated with serotonergic, dopaminergic, and opioid receptors. Aβ deposition co-localized with 5HT2a receptor, γ-aminobutyric acid type A (GABAa) receptors, and noradrenaline transporter (NAT) in AD, as well as D1 receptor in MCI. In AD, FDG or Aβ PET-neurotransmitter correlations significantly associated with MMSE/MoCA scores, while Aβ-serotonin transporter (SERT) or Fluorodopa (FDOPA) correlations linked to cognitive decline in Aβ-positive MCI (P < 0.05). CONCLUSION: This study demonstrates that AD and FTD exhibit unique spatial vulnerabilities in neurotransmitter systems, closely tied to glucose hypometabolism and Aβ pathology. The identification of disease specific neuroimaging-neurotransmitter signatures advances biomarker development and supports targeted therapeutic strategies tailored to molecular pathways. CLINICAL TRIAL NUMBER: not applicable. KEY POINTS: 1. Decreased glucose metabolism in AD and FTD has spatial localization relationship with different neurotransmitter systems.2. Aβ deposition has a co-localization relationship with 5HT2a, GABAa, NAT, and D1 distribution in AD or MCI.3. In AD, FDG or Aβ PET-neurotransmitter correlations significantly associated with MMSE/MoCA scores, while Aβ PET-SERT or FDOPA correlations linked to cognitive decline in Aβ-positive MCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology & Nuclear Medicine, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Xicheng District, Beijing, 100053, China.
- Beijing Key Laboratory of Magnetic Resonance Imaging and Brain Informatics, Beijing, China.
- Key laboratory of Neurodegenerative diseases, Ministry of Education, Beijing, China.
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
- Department of Radiology & Nuclear Medicine, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Xicheng District, Beijing, 100053, China. yansz_me@ccmu.edu.cn.
- Beijing Key Laboratory of Magnetic Resonance Imaging and Brain Informatics, Beijing, China. yansz_me@ccmu.edu.cn.
ORCID-Profile: Shaozhen Yan
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Bi, S., Chen, Z., Li, Y., Cui, B., Shan, Y., Yang, H., Qi, Z., Wu, L., Yan, S., & Lu, J. (2026). Glucose metabolism alterations and Aβ deposition in AD and FTD are related to the distribution of neurotransmitter systems. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-025-07485-8
Vancouver
Bi S, Chen Z, Li Y, Cui B, Shan Y, Yang H, et al. Glucose metabolism alterations and Aβ deposition in AD and FTD are related to the distribution of neurotransmitter systems. European Journal of Nuclear Medicine and Molecular Imaging. 2026. doi:10.1007/s00259-025-07485-8
BibTeX
@article{Bi2026,
author = {Bi, Sheng and Chen, Zhigeng and Li, Yixia and Cui, Bixiao and Shan, Yi and Yang, Hongwei and Qi, Zhigang and Wu, Liyong and Yan, Shaozhen and Lu, Jie},
title = {Glucose metabolism alterations and Aβ deposition in AD and FTD are related to the distribution of neurotransmitter systems},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
doi = {10.1007/s00259-025-07485-8}
}
EUVIMED